Q/C Technologies, Inc. Dividends, Preferred Stock, Cash
Q/C Technologies, Inc. (QCLS) reported Dividends, Preferred Stock, Cash of $901.90 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Shareholders' Equity › Dividends
us-gaap:DividendsPreferredStockCash · last filed 2025-11-19
- Q/C Technologies, Inc. dividends, preferred stock, cash for the quarter ending 2025-09-30 was $901.90K, a 20.09% increase year-over-year.
- Q/C Technologies, Inc. dividends, preferred stock, cash for the quarter ending 2025-06-30 was $976.37K, a 25.60% increase year-over-year.
- Q/C Technologies, Inc. dividends, preferred stock, cash for the quarter ending 2025-03-31 was $813.50K, a 32.31% decline year-over-year.
- Q/C Technologies, Inc. dividends, preferred stock, cash for the quarter ending 2024-09-30 was $751.05K, a 91.82% increase year-over-year.
- Q/C Technologies, Inc. dividends, preferred stock, cash for fiscal 2024 was $3.80M.
| Period end | Dividends, Preferred Stock, Cash 3 month | Dividends, Preferred Stock, Cash 6 month | Dividends, Preferred Stock, Cash 9 month | Dividends, Preferred Stock, Cash 12 month |
|---|---|---|---|---|
| 2025-09-30 | $901.90K 10-Q · filed 2025-11-19 | $1.88M derived: sum of 2 quarters · filed 2025-11-19 | $2.69M derived: sum of 3 quarters · filed 2025-11-19 | |
| 2025-06-30 | $976.37K 10-Q · filed 2025-11-19 | $1.79M derived: sum of 2 quarters · filed 2025-11-19 | ||
| 2025-03-31 | $813.50K 10-Q · filed 2025-11-19 | |||
| 2024-12-31 | $3.80M 10-K · filed 2025-04-11 | |||
| 2024-09-30 | $751.05K 10-Q · filed 2024-11-14 | $1.53M derived: sum of 2 quarters · filed 2025-11-19 | $2.73M derived: sum of 3 quarters · filed 2025-11-19 | |
| 2024-06-30 | $777.34K 10-Q · filed 2025-11-19 | $1.98M derived: sum of 2 quarters · filed 2025-11-19 | ||
| 2024-03-31 | $1.20M 10-Q · filed 2025-11-19 | |||
| 2023-09-30 | $391.55K 10-Q · filed 2024-11-14 | $765.34K derived: sum of 2 quarters · filed 2024-11-14 | $923.68K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $373.80K 10-Q · filed 2024-11-14 | $532.13K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $158.33K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |